Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Web-based prognostic assessment tool study for major depressive disorder in primary care
NL-OMON37874Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Primary endpoints: Website feasibility, Website usability and 2 more. Started Apr 2012; status: active, not recruiting.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON37874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37874.